Trials / Completed
CompletedNCT00979615
Safety and Efficacy of Olopatadine 0.6% and Azelastine 137 Mcg in Vasomotor Rhinitis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 129 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine safety and efficacy of Patanase and Astelin in treating the symptoms of non-allergic vasomotor rhinitis (VMR).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Olopatadine HCL (Patanase) Nasal Spray, 0.6% | 2 sprays/ nostril BID |
| DRUG | Azelastine HCl (Astelin) Nasal Spray, 137 mcg | 2 sprays/ nostril BID |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2009-11-01
- First posted
- 2009-09-18
- Last updated
- 2011-05-10
- Results posted
- 2011-05-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00979615. Inclusion in this directory is not an endorsement.